Cerus Corporation (Nasdaq: CERS) announced today that it has been awarded an additional $7.2 million contract amendment by the U.S. Department of Defense (DoD) Industrial Base Analysis and Sustainment (IBAS)…
Next-Generation NeoCast™ Liquid Embolic Offers Pain-Free Treatment and Rapid Healing for Chronic Subdural Hematoma Arsenal Medical, a clinical-stage company developing innovative biomaterials-based devices, today announced late-breaking data from the EMBO-02…
BioAffinity Technologies Receives China Patent for Its Noninvasive Lung Cancer Diagnostic Tool A biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung, the Company’s commercially available test for early-stage lung cancer,…
SBC Medical Group Appoints Renowned Plastic Surgery Expert Dr. Steven R. Cohen as Medical Strategy Advisor to Drive Global Expansion SBC Medical Group Holdings (headquarters: California, USA; CEO: Yoshiyuki Aikawa)…
Elegen , a leading next-generation DNA manufacturer, and Nutcracker Therapeutics , a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot program to demonstrate the industry’s first…
Parse Biosciences, a leading provider of easy-to-use and scalable single-cell sequencing solutions, today announced that a groundbreaking study published in Science used Parse’s single-cell technology to reveal how signaling pathways drive the formation of…
KVC Health Systems and WellSky® Partner to Improve Behavioral Health Care WellSky, a global health and community care technology and services company, today announced that KVC Health Systems, a national leader…
A global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has developed a dual-active material science technology engineered to simultaneously control moisture and…
A technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of its care pathway intelligence platform, Tempus Next, into breast cancer. Since…
Modella AI, a leader in artificial intelligence for life sciences, today announced a multi-year agreement with AstraZeneca. Under the agreement, Modella AI will provide access to its state-of-the-art multi-modal AI…
Predictmedix AI Launches Mobile Platform for AI-Powered Diabetes Screening A leader in artificial intelligence-driven health screening solutions, is expanding into the direct-to-consumer market with a mobile solution designed to deliver…
Cleerly, the leader in cardiovascular imaging, today announced the promotions of two key executives to expanded leadership roles. Dr. Udo Hoffmann, MD, MPH, has been promoted to Chief Medical, Scientific…